AVANTEL LTD.

Avantel Ltd has received a Monitoring Agency Report from CARE Ratings Limited for the quarter ended June 30, 2026. The report confirms that the proceeds from the company's Rights Issue have been utilized for the purposes outlined in the Letter of Offer, with no deviation or variation. The report was reviewed and taken on record by Avantel's Audit Committee and Board of Directors on July 11, 2026. The Rights Issue aggregated to Rs. 80.91 crore.

Avantel Ltd announced that its Board of Directors, in a meeting held on July 11, 2026, approved key personnel changes and committee re-constitutions. Mr. Abburi Siddhartha Sagar was re-appointed as Executive Director (Strategy & Business Development) for five years from March 8, 2027. Mr. Peddi Bala Bhaskar Rao was appointed as Additional Director (Operations) for three years from July 11, 2026. Mr. Vyasabhattu Ramchander was re-appointed as Independent Director for a second five-year term from May 6, 2027. All appointments are subject to shareholder approval via postal ballot. The Board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee.

Avantel Ltd announced that its Board of Directors, in a meeting held on July 11, 2026, approved key personnel changes and committee reconstitutions. Mr. Abburi Siddhartha Sagar was re-appointed as Executive Director (Strategy & Business Development) for five years from March 8, 2027. Mr. Peddi Bala Bhaskar Rao was appointed as an Additional Director, Director (Operations) for three years from July 11, 2026. Mr. Vyasabhattu Ramchander was re-appointed as an Independent Director for a second five-year term from May 6, 2027. All appointments are subject to shareholder approval via postal ballot. The Board also reconstituted the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee with immediate effect.

Avantel Ltd announced that its Board of Directors, in a meeting held on July 11, 2026, approved the un-audited standalone and consolidated financial results for the first quarter and three months ended June 30, 2026. The board also approved a revision in remuneration for Executive Director Mr. Abburi Siddhartha Sagar to ₹55 Lakhs per annum, effective July 11, 2026. Additionally, the re-appointment of Mr. Sagar as Executive Director for a further five-year term and the appointment of Mr. Peddi Bala Bhaskar Rao as Additional Director (Operations) for three years were approved, subject to shareholder approval via postal ballot. The re-appointment of Mr. Vyasabhattu Ramchander as Independent Director for a second five-year term was also approved, pending shareholder consent. The Audit Committee, Nomination and Remuneration Committee, and Stakeholders' Relationship Committee were reconstituted.

Avantel reported strong Q1 FY-2027 results with consolidated revenue ₹70.42 Cr, up 35.6% YoY and 10.3% QoQ, while net profit surged 67.1% to ₹5.39 Cr from ₹3.23 Cr a year ago and ₹4.77 Cr in Q4 FY-2026. The Communications & Signal Processing segment (core business, 99.6% of revenue) delivered ₹70.23 Cr and PBT of ₹10.92 Cr; the wholly-owned Healthcare subsidiary (iMeds) contributed only ₹30.4 Lakhs in revenue but posted a ₹2.22 Cr loss. Operating margin compressed sharply to 12.4% from 20.1% YoY and 21.3% QoQ, driven by elevated depreciation of ₹7.10 Cr stemming from recent capex investment in manufacturing infrastructure; net profit margin expanded to 7.7% YoY (from 6.2%) but was flat QoQ (7.35%). The 29% gap between standalone PAT (₹7.62 Cr) and consolidated (₹5.39 Cr) reflects the healthcare subsidiary's drag—a structural issue investors should monitor as management develops this segment. Consolidated EPS declined to ₹0.20 from ₹0.32 YoY despite strong profit growth, indicating material share dilution from ESOP issuance (₹135.59 Lakhs in option expense this quarter). The company's principal customer is government-controlled, eliminating loss allowance risk. Strong topline growth (+36% YoY) and profit expansion (+67%) demonstrate solid business momentum, but the significant margin compression warrants close monitoring to assess whether capex-driven depreciation represents a cyclical trough or signals structural operating leverage challenges. Management has not provided FY-2027 guidance.

Avantel Ltd has announced that its Board of Directors will convene on July 11, 2026, to consider and approve the Unaudited Financial Results for the First Quarter ended June 30, 2026. In line with SEBI regulations, the company has also closed its trading window from July 1, 2026, and it will remain shut for 48 hours post-declaration of the financial results to prevent insider trading. This announcement is made in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Avantel Ltd has announced the receipt of a firm Purchase Order from M/s. Zetwerk Manufacturing Businesses Limited, valued at ₹83.80 Crores (inclusive of applicable taxes). This order is pursuant to an earlier Rate Contract awarded to Avantel. The scope of the order involves the supply of Satellite Communication Equipment and includes a one-year comprehensive onsite warranty. The execution of this order is expected by March 2027. This significant order underscores Avantel's capabilities in the satellite communication sector and its ongoing business relationship with Zetwerk Manufacturing Businesses Limited.

Avantel Limited has announced the closure of its trading window for dealing in the company's securities, effective July 1, 2026. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and relevant BSE and NSE circulars. The window will reopen 48 hours after the Board of Directors meeting where the Un-audited Financial Results for the First Quarter ended June 30, 2026, are considered and approved. The closure applies to all Designated Persons, their immediate relatives, and connected persons. The specific date of the Board Meeting will be communicated separately.

Avantel Ltd announced the re-appointment of M/s. Grandhy & Co., Chartered Accountants, as its Statutory Auditors for a second term of five years, from the conclusion of the 36th AGM until the 41st AGM (FY 2030-31). The company also appointed Dr. Tamilmani Kandasamy and Mr. Lakshminarasimha Acharyulu Muktevi as Independent Directors for a five-year term commencing April 26, 2026. These decisions were approved by the company's members at the 36th Annual General Meeting held on June 24, 2026. Grandhy & Co. has over five decades of experience and is empanelled with major regulatory authorities.

Avantel Ltd announced key decisions made at its 36th Annual General Meeting held on June 24, 2026. The company's members approved the re-appointment of M/s. Grandhy & Co. as Statutory Auditors for a second five-year term, concluding with the Financial Year 2030-31. Additionally, Dr. Tamilmani Kandasamy (DIN: 07617444) and Mr. Lakshminarasimha Acharyulu Muktevi (DIN: 02118771) were appointed as Independent Directors for a five-year term, commencing April 26, 2026, and ending April 25, 2031. These appointments are in compliance with SEBI LODR Regulations, 2015.